COVID-19 is the infectious disease caused by the new coronavirus (SARS-CoV-2) identified in late 2019. COVID-19 is affecting many countries globally and has been declared a pandemic by the World Health Organization (WHO).

About VLA2001

  • VLA2001 is a Vero-cell based, highly purified inactivated vaccine candidate against the SARS-CoV-2 virus, developed using the same manufacturing platform as Valneva’s Japanese encephalitis vaccine.
  • Valneva announced the initiation of the vaccine program in April 2020.

Additional information about COVID-19